Press Releases
June 28, 2010
Takeda Pharmaceutical Company Limited
Takeda Appoints Two Executive-level Personnel from Outside the Company
Osaka, Japan, June 28, 2010 --- Takeda Pharmaceutical Company Limited (“Takeda”) announced at the extraordinary Board of Directors’ Meeting held on June 25th, 2010, it resolved to appoint Frank Morich, M.D., Ph.D. as Executive Vice President (EVP), International Operations, effective October 1, 2010, and also to appoint Mr. Haruhiko Hirate as Corporate Officer, Senior Vice President, effective July 1, 2010.
Dr. Frank Morich, after holding important roles in Bayer AG, is currently CEO of NOXXON Pharma, and also is one of the Takeda Global Advisory Board[*] members. As EVP, International Operations, Dr. Frank Morich will be responsible for enhancing Takeda’s commercial operations and the company’s presence outside Japan.
Dr. Morich will succeed Mr. Alan MacKenzie who announced his retirement earlier this year after 25 years of service to Takeda. Mr. MacKenzie currently is the founding EVP of the International Operations organization, and until most recently served as a member of the Takeda Board of Directors.
Mr. Haruhiko Hirate , after holding the president position in Roche Diagnostics K.K., Japan and Banyu Pharmaceutical Co., Ltd., was Senior Managing Director and Representative Director of Glaxo SmithKline, K.K., Japan until recently where he was in charge of overall sales and marketing functions. As Corporate Officer, Senior Vice President, Mr. Haruhiko Hirate will contribute to the management and operation of the company with his expertise and experience.
“I am very much pleased to welcome to Takeda Dr. Morich and Mr. Hirate, who both have vast pharmaceutical expertise and experience,” said Yasuchika Hasegawa, President & CEO of Takeda. “I believe Dr. Morich and Mr. Hirate will contribute a lot to our company so that we can realize a transformation to a New Takeda during the period of our 2010 to 2012 Mid-Range Plan. Implementing a novel strategic approach is indispensable for Takeda to achieve long-term, sustainable growth”.
[*] Takeda Global Advisory Board (TGAB)
TGAB was established in June 2009, and consists of four external Advisors with executive level experience at global pharmaceutical companies. The TGAB discusses variety of managerial topics with Takeda’s top management and provides the company with valuable guidance which is being reflected in the management strategies of Takeda.
# # #
About Takeda Pharmaceutical Company Limited
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Additional information about Takeda is available through its corporate website, www.takeda.com.
# # #
Profiles of Dr. Morich and Mr. Hirate
Frank Morich, MD, PhD
| Graduated in Medicine at the University of Marburg, specializing in immunology and oncology | |
| 1982: | Joined Bayer AG’s Pharmaceutical Division; Head of Global Research & Development and Global Product Development |
| 1998: | General Manager of Bayer AG's Consumer Care Division |
| 2000: | Member of the Board of Management, Bayer AG and BOD Bayer Corp |
| 2002: | Chairman of the Board of Management, Bayer HealthCare, and Member of the Senate, Fraunhofer Society for Applied Research |
| 2004: | CEO, AM-Pharma; Chairman, Scientific Advisory Board, Forbion; BOD Innate Pharma |
| 2005: | CEO and Member BOD, Innogenetics; BOD AM-Pharma |
| 2008: | CEO NOXXON Pharma |
Mr. Haruhiko Hirate
| Graduated from Economics, Keio University | |
| 1980: | Joined Nissei Sangyo Co., Ltd. (Subsidiary of Hitachi, Ltd.) |
| 1983: | Nissei Sangyo GmbH (Deutschland) Mannheim office, Manager |
| Oct. 1996: | Draeger Japan Ltd. Representative Director and President, Japan |
| Jan. 1999: | Draeger Medizintechnik GmbH, Regional Director Asia Pacific and Representative Director and President, Draeger Japan |
| Jan. 2001: | Roche Diagnostics K.K. Representative Director and President |
| Jan. 2004: | Banyu Pharmaceutical Co., Ltd. Representative Director and President |
| Jul. 2008: | GlaxoSmithKline K.K. Representative Director and Managing Director (up to March 2010) |
# # #